The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 0.00 (0.00%)
Spread: 0.50 (0.029%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,733.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BUZZ-U.S. STOCKS ON THE MOVE-Apple, SunEdison, HMS Holdings, Abercrombie

Mon, 24th Aug 2015 17:10

(For faster updates on individual market-movers, Eikon usersplease use search string "STXBZ US"; for the Day Aheadnewsletter, http://link.reuters.com/mex49s; for the Morning NewsCall newsletter, http://link.reuters.com/nex49s)U.S. stock indexes were down on Monday. The Dow Jones industrialaverage was down 0.76 percent at 16,333.98, the S&P 500 was down 0.96 percent at 1,952.06 and the NasdaqComposite was down 0.92 percent at 4,662.53.

For a Breakingviews column, Investors' self-doubt worsensequity woes

** APPLE INC, $108.0301, +2.15 pct

The iPhone maker's shares rebounded sharply off day's lows,helping U.S. stocks stage a dramatic recovery. The shares openedmore than 10 percent lower in heavy trading. Stock still off afifth from February's record high.

For a Breakingviews column, Tech's real China syndromevictims are yet to fall

** BANK OF AMERICA CORP, $15.96, -0.87 pct

** CITIGROUP INC, $52.42, -2.20 pct

** MORGAN STANLEY, $33.47, -2.16 pct

** JPMORGAN CHASE & CO, $62.78, -1.29 pct

** GOLDMAN SACHS GROUP INC, $186.43, -0.70 pct

** WELLS FARGO & CO, $53.05, -1.70 pct

U.S. bank stocks continued to slide after last week's Fedminutes suggested the central bank may not raise interest ratesin September due to international developments, including weakeryuan.

Traders now see a 24 percent chance that Fed will increaserates in September, down from 30 percent late on Friday and 46percent a week earlier, according to Tullett Prebon data.

** NETFLIX INC, $106.57, +2.51 pct

** GENERAL MOTORS CO, $28.77, -2.80 pct

** TESLA MOTORS INC, $229.73, -0.45 pct

** CATERPILLAR INC, $74.67, -0.44 pct

** UNITED STATES STEEL CORP, $16.09, +1.13 pct

** ALCOA INC, $8.53, -2.29 pct

** YUM BRANDS, $78.61, -1.37 pct

Shares of U.S. companies fell at the open on China worries,though a handful of tech stocks were fighting against thebroadly weak market.

** SOLARCITY, $46.8701, +14.35 pct

** SUNEDISON INC, $11.61, +8.30 pct

The stocks snapped back from sharp plunges, with SolarCityup 11.5 percent after being down 15 percent in early trading.The relief rally comes one day after hedge fund manager JimChanos of Kynikos Associates said he was "short SolarCityshares" and criticized both companies' business models.

** ALIBABA GROUP HOLDING LTD, $66.92, -1.85 pct

** JD.COM INC, $24.765, -1.14 pct

** BAIDU INC, $144.395, -5.57 pct

** SINA CORP, $35.28, -2.65 pct

** YOUKU TUDOU, $16.18, -3.75 pct

** YY INC, $54.96, -7.19 pct

** CHINA DANGDANG, $6.3, -4.83 pct

** JUMEI INTERNATIONAL HOLDING, $10.78, -8.33 pct

U.S.-listed shares of Chinese technology companies fellafter Chinese indexes post their biggest one-day percentagelosses since the height of the financial crisis.

** EXXON MOBIL CORP, $70.82, -1.82 pct

** CONOCOPHILLIPS, $44.77, -1.37 pct

** CHEVRON CORP, $74.94, -1.08 pct

Oil prices fell more than 6 percent to fresh 6-1/2-year lowsas markets worried about a China-led global economic slowdownthat would drastically hit oil consumption at a time ofplentiful supply.

S&P 500 oil & gas, oilfield services companies havealready lost about $310 billion in market value this year.

For a Breakingviews column, Oil has room to get even moreirrational

** GLAXOSMITHKLINE PLC, $1,270.53703, -3.21 pct

** MERCK & CO, $54.81, -1.72 pct

** JOHNSON & JOHNSON, $95, -0.59 pct

** BIOGEN INC, $294.82, -0.28 pct

** CELGENE CORP, $118.59, -0.39 pct

** ELI LILLY & CO, $82.76, -2.09 pct

** BRISTOL-MYERS SQUIBB CO, $60.88, -0.31 pct

** PFIZER INC, $33.21 -0.98 pct

** AMGEN INC, $153.58 -1.04 pct

** GILEAD SCIENCES INC, $106.08 +0.71 pct

The S&P 500 Healthcare sector index declined 3percent to 801.97, Nasdaq Biotechnology index down nearly4 percent at 3436.71

** OCATA THERAPEUTICS INC, $4.5816 +20.25 pct

The drug developer awarded Small Business InnovationResearch grant from National Institute of Allergy and InfectiousDiseases, part of National Institutes of Health.

** EPIZYME INC, $18.9 +18.64 pct

The drug developer said U.S. Food and Drug Administrationaccepted its application to start clinical studies of its leadcancer drug, Tazemetostat.

** HMS HOLDINGS CORP, $10.73 +21.38 pct

The New York State Office of the Medicaid Inspector Generalawarded the healthcare facility provider a contract for Medicaidthird-party liability match and recovery services.

** HUBBELL INC, $113.25 +22.68 pct

The electrical equipment maker said it plans to reclassifycommon stock to eliminate its existing two-class structure.

** GEVO INC, $2.54 +10.92 pct

The chemical maker and Butamax Advanced Biofuels LLC, ajoint venture between BP and DuPont, ended apatent dispute related to the production of bio-based fueladditive, isobutanol, and entered into cross-license andsettlement agreements.

** ABERCROMBIE & FITCH CO, $17.58 +6.87 pct

Piper Jaffray upgrades the apparel retailer's stock to"overweight" from "neutral" and raises price target by $2 to$27.

** AGL RESOURCES INC, $62.01, +29.57 pct

** SOUTHERN CO, $44.58, -2.66 pct

Power producer Southern said it would buy AGL Resources forabout $8 billion in cash to become the No. 2 U.S. utility bycustomers after Exelon Corp.

** VITAL THERAPIES INC, $4.02, -77.26 pct

The drug developer said it would stop two ongoing trialstesting its cell-therapy, ELAD, after it failed a late-stagestudy in liver failure patients.

** CHINACACHE INTERNATIONAL HOLDINGS LTD, $6.02,+7.69 pct

The China-based network service provider plans to buy backup to $6 million worth of outstanding ADSs over the next 12months. This is in addition to ChinaCache's existing $10 millionshare buyback.

** EXELIXIS INC, $5.455, +3.90 pct

The U.S. FDA granted the drugmaker's lead drug,cabozantinib, "breakthrough therapy" status to treat patientswith the most common form of kidney cancer.

(Compiled by Arunima Banerjee in Bengaluru; Editing by SrirajKalluvila)

More News
12 Feb 2024 08:35

TOP NEWS: GSK's bepirovirsen receives US FDA fast track designation

(Alliance News) - GSK PLC on Monday said that the US health watchdog granted fast track designation for its bepirovirsen treatment for chronic hepatitis B.

Read more
12 Feb 2024 07:50

LONDON BRIEFING: Tritax Big Box, UK Commercial Property agree merger

(Alliance News) - Equities in London are called to open higher on Monday, with inflation readings from the US and UK on the horizon, which could drive equity market sentiment during the remainder of the week.

Read more
12 Feb 2024 07:21

GSK gets FDA fast track for chronic hepatitis B treatment

(Sharecast News) - GSK announced on Monday that bepirovirsen, an investigational antisense oligonucleotide (ASO) aimed at treating chronic hepatitis B (CHB), had been granted fast track designation by the US Food and Drug Administration (FDA).

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
6 Feb 2024 08:51

TOP NEWS: GSK reports positive news on trio of high profile products

(Alliance News) - GSK PLC on Tuesday delivered a triple dose of positive updates on some of its leading products, Arexvy, Shingrix and Blencep.

Read more
6 Feb 2024 07:47

LONDON BRIEFING: BP promises buyback despite drop in profit

(Alliance News) - Stocks in London are called to open higher, ahead of a slew of construction purchasing managers' index readings from the eurozone, the UK and Germany.

Read more
6 Feb 2024 07:23

GSK reports positive myeloma trial results, progresses vaccine applications

(Sharecast News) - GSK reported progress in its trial of a myeloma treatment on Tuesday, as well as regulatory progress around its shingles vaccine in China and its RSV vaccine in the United States.

Read more
1 Feb 2024 09:27

TOP NEWS: GSK maintains "vigorous" defence after settling Zantac case

(Alliance News) - GSK PLC on Thursday insisted upon its scientific integrity, after reaching another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
1 Feb 2024 09:11

GSK settles Zantac case in California without admitting liability

(Sharecast News) - GSK announced on Thursday that it had reached a confidential settlement to effectively resolve the legal case over Zantac filed in a California state court.

Read more
1 Feb 2024 09:03

LONDON BROKER RATINGS: Barclays cuts Next; JPMorgan raises easyJet

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
1 Feb 2024 07:42

LONDON BRIEFING: Shell profit falls; announces USD3.5 billion buyback

(Alliance News) - Stocks in London are set to follow New York into the red, after the US Federal Reserve quashed hopes of a March cut to interest rates and ahead of the Bank of England interest rate decision.

Read more
31 Jan 2024 17:05

LONDON MARKET CLOSE: Stocks mixed hours before expected US Fed hold

(Alliance News) - Stock prices in London closed mixed on Wednesday in a trade-thinned day ahead of the US Federal Reserve interest rate decision this evening.

Read more
31 Jan 2024 15:49

London close: Stocks mixed ahead of US Fed, BoE decisions

(Sharecast News) - London's financial markets finished with mixed performance on Wednesday, with investors closing their wallets ahead of rate announcements from both the US Federal Reserve and the Bank of England.

Read more
31 Jan 2024 12:05

LONDON MARKET MIDDAY: FTSE 100 flat ahead of Federal Reserve decision

(Alliance News) - The FTSE 100 in London was flat heading into Wednesday afternoon, as the US Federal Reserve's latest interest rate decision edges closer, keeping equity market enthusiasm to a minimum.

Read more
31 Jan 2024 09:13

TOP NEWS: GSK profit up on Arexvy boost in 2023 but total payout down

(Alliance News) - GSK PLC reported an increase in profit and revenue for 2023 as revenue for HIV medicine had stable growth, amid optimism in the company's outlook.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.